Biogen Idec ($BIIB) and Columbia University Medical Center have struck a $30 million genetics R&D alliance. Some of the cash will go toward creating a sequencing and analysis center at Columbia to support collaborative research. Biogen hopes to generate qualified targets for new therapeutics by investigating the genomes of people who respond unusually to treatment. Release